Under construction – not a live service
Sign in
Taking people in MalaysiaNo phase

Testing a rapid HIV treatment start for people who inject drugs

Tests a rapid-start HIV medicine approach in adults who inject drugs and have HIV.

Plain-language title generated from the registry record
Registry title: Reducing Stigma in People Who Inject Drugs (PWID) With HIV Using a Rapid Start Antiretroviral Therapy Intervention (ART)

Key facts

Where
Kajang and Kuala Lumpur, MalaysiaSee the 3 sites

Where in Malaysia

  • Kajang PrisonKajang, MalaysiaTaking people
  • Primary Healthcare CentersKuala Lumpur, MalaysiaTaking people
  • Centre of Excellence for Research in AIDS (CERiA) - University of MalayaKuala Lumpur, MalaysiaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Yale University
Trial code
NCT06541028
Record updated
10 September 2026
Original description
This study seeks to develop an RS-ART implementation strategy by utilizing the Delphi method and interviewing experts and PWID regarding their experiences with ART. This strategy will then be pilot tested in a randomized controlled trial (Aim 3). The research will not impact the type of medication and dose prescribed, but rather, how soon providers are able to prescribe ART after diagnosis. The focus of this registration is Aim 3.Read full original descriptionShow less

Reducing Stigma in People Who Inject Drugs With HIV Using a Rapid Start Antiretroviral Therapy Intervention (RS-ART)

This study seeks to develop an RS-ART implementation strategy by utilizing the Delphi method and interviewing experts and PWID regarding their experiences with ART. This strategy will then be pilot tested in a randomized controlled trial (Aim 3). The research will not impact the type of medication and dose prescribed, but rather, how soon providers are able to prescribe ART after diagnosis. The focus of this registration is Aim 3.

Inclusion: PWID in general population:; Be a PWID from the general population enrolling into ART services at one of the study's HIV clinics. PWID can include patients injecting opioids, amphetamines, or other combinations of injectable drugs. Some of these patients may be diagnosed with Opioid Use Disorder (OUD); Provide informed consent; HIV clinicians prescribing ART; Be the HIV clinician who prescribes ART for a PWID in one of the selected clinics; Be willing to use the RS-ART protocol; Be at least 18 years old. No minors below age 18 will be enrolled in the study; Provide informed consent; PWID in prison population:; Be a PWID enrolling into ART services at Kajang prison. PWID can include patients injecting opioids, amphetamines, or other combinations of injectable drugs. Some of these patients may be diagnosed with Opioid Use Disorder (OUD); Provide informed consent.

Exclusion: -.

ClinicalTrials.gov NCT06541028